The DOI matches its Crossref record; 155 of the 155 references it cites were found in a registry or an index.
Myelination and mTOR
Open accessAbstract
Myelinating cells surround axons to accelerate the propagation of action potentials, to support axonal health, and to refine neural circuits. Myelination is metabolically demanding and, consistent with this notion, mTORC1—a signaling hub coordinating cell metabolism—has been implicated as a key signal for myelination. Here, we will discuss metabolic aspects of myelination, illustrate the main metabolic processes regulated by mTORC1, and review advances on the role of mTORC1 in myelination of the central nervous system and the peripheral nervous system. Recent progress has revealed a complex role of mTORC1 in myelinating cells that includes, besides positive regulation of myelin growth, additional critical functions in the stages preceding active myelination. Based on the available evidence, we will also highlight potential nonoverlapping roles between mTORC1 and its known main upstream pathways PI3K‐Akt, Mek‐Erk1/2, and AMPK in myelinating cells. Finally, we will discuss signals that are already known or hypothesized to be responsible for the regulation of mTORC1 activity in myelinating cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The PI3K/ AKT/mTOR signaling pathway broadly promotes brain growth and development of the myelin sheath [32–35].”
From Neandertal Introgression Sheds Light on Modern Human Endocranial Globularity (2019) · cites this paper as [35]
Experimental — accuracy not yet measuredIn the citing paper
“In addition, oligodendrocyte autophagy, OPC differentiation, and myelination during development are all regulated by MTOR [445–447].”
From Autophagy and ALS: mechanistic insights and therapeutic implications (2022) · cites this paper as [446]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
mTOR Signaling in Growth, Metabolism, and Disease
Saxton, R. A., & Sabatini, D. M. (2017) · Cell · doi:10.1016/j.cell.2017.02.004 · Cited by 7,555
AMPK: a nutrient and energy sensor that maintains energy homeostasis
Hardie, D. G., Ross, F. A., & Hawley, S. A. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3311 · Cited by 4,602
TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
Inoki, K., Zhu, T., & Guan, K.-L. (2003) · Cell · doi:10.1016/s0092-8674(03)00929-2 · Cited by 3,914
AKT/PKB Signaling: Navigating the Network
Manning, B. D., & Toker, A. (2017) · Cell · doi:10.1016/j.cell.2017.04.001 · Cited by 3,772
Molecular mechanisms of mTOR-mediated translational control
Ma, X. M., & Blenis, J. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2672 · Cited by 2,558
Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB
Sarbassov, D. D., Ali, S. M., Sengupta, S., Sheen, J.-H., Hsu, P. P., Bagley, A. F., Markhard, A. L., & Sabatini, D. M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.029 · Cited by 2,365
mTOR Signaling in Growth, Metabolism, and Disease
Saxton, R. A., & Sabatini, D. M. (2017) · Cell · doi:10.1016/j.cell.2017.03.035 · Cited by 2,112
Activation of a metabolic gene regulatory network downstream of mTOR complex 1
Düvel, K., Yecies, J. L., Menon, S., Raman, P., Lipovsky, A. I., Souza, A. L., Triantafellow, E., Ma, Q., Gorski, R., Cleaver, S., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.06.022 · Cited by 2,020
Biology of Oligodendrocyte and Myelin in the Mammalian Central Nervous System
Baumann, N., & Pham-Dinh, D. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.871 · Cited by 1,828
M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination
Miron, V. E., Boyd, A., Zhao, J.-W., Yuen, T. J., Ruckh, J. M., Shadrach, J. L., van Wijngaarden, P., Wagers, A. J., Williams, A., Franklin, R. J. M., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3469 · Cited by 1,777 · cited 1×
“Moreover, M2-type microglia and blood-derived macrophages were shown to promote remyelination by secreting activin-A, potentially contributing to mTORC1 activation in OL-lineage cells (Miron et al., 2013).”
Flagged first, then by citations
Cited by
Sorted by citations
Repair Schwann cell update: Adaptive reprogramming, EMT, and stemness in regenerating nerves
Jessen, K. R., & Arthur‐Farraj, P. (2019) · Glia · doi:10.1002/glia.23532 · Cited by 350
Molecular Control of Oligodendrocyte Development
Elbaz, B., & Popko, B. (2019) · Trends in Neurosciences · doi:10.1016/j.tins.2019.01.002 · Cited by 304
Autophagy and ALS: mechanistic insights and therapeutic implications
Chua, J. P., De Calbiac, H., Kabashi, E., & Barmada, S. J. (2022) · Autophagy · doi:10.1080/15548627.2021.1926656 · Cited by 189
The neuromuscular junction is a focal point of mTORC1 signaling in sarcopenia
Ham, D. J., Börsch, A., Lin, S., Thürkauf, M., Weihrauch, M., Reinhard, J. R., Delezie, J., Battilana, F., Wang, X., Kaiser, M. S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18140-1 · Cited by 180
mTOR/AMPK signaling in the brain: Cell metabolism, proteostasis and survival
Garza-Lombó, C., Schroder, A. L., Reyes‐Reyes, E. M., & Franco, R. (2018) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2018.05.002 · Cited by 169
mTOR and neuroinflammation in epilepsy: implications for disease progression and treatment
Ravizza, T., Scheper, M., Di Sapia, R., Gorter, J., Aronica, E., & Vezzani, A. (2024) · Nature Reviews Neuroscience · doi:10.1038/s41583-024-00805-1 · Cited by 141
Local cholesterol metabolism orchestrates remyelination
Berghoff, S. A., Spieth, L., & Saher, G. (2022) · Trends in Neurosciences · doi:10.1016/j.tins.2022.01.001 · Cited by 145
Sun, L. O., Mulinyawe, S. B., Collins, H. Y., Ibrahim, A., Li, Q., Simon, D. J., Tessier‐Lavigne, M., & Barres, B. A. (2018) · Cell · doi:10.1016/j.cell.2018.10.044 · Cited by 133
Neandertal Introgression Sheds Light on Modern Human Endocranial Globularity
Gunz, P., Tilot, A. K., Wittfeld, K., Teumer, A., Shapland, C. Y., van Erp, T. G. M., Dannemann, M., Vernot, B., Neubauer, S., Guadalupe, T., et al. (2019) · Current Biology · doi:10.1016/j.cub.2018.10.065 · Cited by 117
Myelin lipid metabolism and its role in myelination and myelin maintenance
Barnes-Vélez, J. A., Aksoy Yasar, F. B., & Hu, J. (2023) · The Innovation · doi:10.1016/j.xinn.2022.100360 · Cited by 73
Curatolo, P., Specchio, N., & Aronica, E. (2022) · The Lancet Neurology · doi:10.1016/s1474-4422(22)00213-7 · Cited by 119
Advances of Schwann cells in peripheral nerve regeneration: From mechanism to cell therapy
Wei, C., Guo, Y., Ci, Z., Li, M., Zhang, Y., & Zhou, Y. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116645 · Cited by 111
Wu, F., Xu, K., Liu, L., Zhang, K., Xia, L., Zhang, M., Teng, C., Tong, H., He, Y., Xue, Y., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00406 · Cited by 95
Lipids in regulating oligodendrocyte structure and function
Montani, L. (2020) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2020.07.016 · Cited by 99
The Endocannabinoid System and Oligodendrocytes in Health and Disease
Ilyasov, A. A., Milligan, C. E., Pharr, E., & Howlett, A. C. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00733 · Cited by 91
Ishii, A., Furusho, M., Macklin, W. B., & Bansal, R. (2019) · Glia · doi:10.1002/glia.23602 · Cited by 88
Robinson, A. P., Zhang, J. Z., Titus, H. E., Karl, M., Merzliakov, M., Dorfman, A. R., Karlik, S., Stewart, M. G., Watt, R. K., Facer, B. D., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-58709-w · Cited by 87
Oligodendrogenesis and myelination regulate cortical development, plasticity and circuit function
Fletcher, J. L., Makowiecki, K., Cullen, C. L., & Young, K. M. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.03.017 · Cited by 82
Galectin-3-Mediated Glial Crosstalk Drives Oligodendrocyte Differentiation and (Re)myelination
Thomas, L., & Pasquini, L. A. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00297 · Cited by 76
Epileptogenesis in tuberous sclerosis complex-related developmental and epileptic encephalopathy
Aronica, E., Specchio, N., Luinenburg, M. J., & Curatolo, P. (2023) · Brain · doi:10.1093/brain/awad048 · Cited by 74
Norrmén, C., Figlia, G., Pfistner, P., Pereira, J. A., Bachofner, S., & Suter, U. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.3619-17.2018 · Cited by 74
Self-citationRivera, A. D., Pieropan, F., Chacon‐De‐La‐Rocha, I., Lecca, D., Abbracchio, M. P., Azim, K., & Butt, A. M. (2021) · Aging Cell · doi:10.1111/acel.13335 · Cited by 61
A hypothesis for the role of axon demyelination in seizure generation
de Curtis, M., Garbelli, R., & Uva, L. (2021) · Epilepsia · doi:10.1111/epi.16824 · Cited by 57
Belgrad, J., Pace, R. D., & Fields, R. D. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.1066-19.2019 · Cited by 63
Precocious myelination in a mouse model of autism
Khanbabaei, M., Hughes, E., Ellegood, J., Qiu, L. R., Yip, R., Dobry, J., Murari, K., Lerch, J. P., Rho, J. M., & Cheng, N. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0590-7 · Cited by 59
Disrupting insulin signaling in Schwann cells impairs myelination and induces a sensory neuropathy
Hackett, A. R., Strickland, A. M., & Milbrandt, J. (2019) · Glia · doi:10.1002/glia.23755 · Cited by 60
Li, M., Meng, N., Guo, X., Niu, X., Zhao, Z., Wang, W., Xie, X., & Lv, P. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00137 · Cited by 51
Ishii, A., Furusho, M., & Bansal, R. (2021) · Glia · doi:10.1002/glia.24049 · Cited by 51
Liu, T., Wang, Y., Lu, L., & Liu, Y. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01337-5 · Cited by 49
Zimmer, T. S., Broekaart, D. W. M., Gruber, V.-E., van Vliet, E. A., Mühlebner, A., & Aronica, E. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.01028 · Cited by 48
Insights into Potential Targets for Therapeutic Intervention in Epilepsy
Zavala‐Tecuapetla, C., Cuéllar‐Herrera, M., & Luna‐Munguía, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228573 · Cited by 50
The Iron Metabolism with a Specific Focus on the Functioning of the Nervous System
Kulaszyńska, M., Kwiatkowski, S., & Skonieczna‐Żydecka, K. (2024) · Biomedicines · doi:10.3390/biomedicines12030595 · Cited by 54
Axo-glial interdependence in peripheral nerve development
Fledrich, R., Kungl, T., Nave, K., & Stassart, R. M. (2019) · Development · doi:10.1242/dev.151704 · Cited by 51
Review: Myelin clearance is critical for regeneration after peripheral nerve injury
Yuan, Y., Wang, Y., Wu, S., & Zhao, M. Y. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.908148 · Cited by 49
Wang, J., Yang, L., Dong, C., Wang, J., Xu, L., Qiu, Y., Weng, Q., Zhao, C., Xin, M., & Lu, Q. R. (2020) · Science Advances · doi:10.1126/sciadv.aaz6477 · Cited by 43
Dysregulation of mTOR Signaling after Brain Ischemia
Villa-González, M., Martín-López, G., & Pérez-Álvarez, M. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052814 · Cited by 41
Sokol, D. K., Maloney, B., Westmark, C. J., & Lahiri, D. K. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00165 · Cited by 38
Brain-enriched RagB isoforms regulate the dynamics of mTORC1 activity through GATOR1 inhibition
Figlia, G., Müller, S., Hagenston, A. M., Kleber, S., Roiuk, M., Quast, J.-P., ten Bosch, N., Ibañez, D. C., Mauceri, D., Martín-Villalba, A., et al. (2022) · Nature Cell Biology · doi:10.1038/s41556-022-00977-x · Cited by 41
Self-citationWarnock, A., Toomey, L. M., Wright, A. J., Fisher, K., Won, Y., Anyaegbu, C. C., & Fitzgerald, M. (2020) · Journal of Neurotrauma · doi:10.1089/neu.2019.6890 · Cited by 36
Şen, N.-E., Arsović, A., Meierhofer, D., Brodesser, S., Oberschmidt, C., Canet-Pons, J., Güleç, Z. E. K., Halbach, M. V., Gispert, S., Sandhoff, K., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235854 · Cited by 35
Kunkel, T. J., Townsend, A., Sullivan, K. A., Merlet, J., Schuchman, E. H., Jacobson, D., & Lieberman, A. P. (2023) · Nature Communications · doi:10.1038/s41467-023-39733-6 · Cited by 37
Xia, W., Zhu, J., Wang, X., Tang, Y., Zhou, P., Hou, M., & Li, S. (2020) · The FASEB Journal · doi:10.1096/fj.202000726rrr · Cited by 32
Δ9‐Tetrahydrocannabinol promotes oligodendrocyte development and CNS myelination in vivo
Huerga-Gómez, A., Aguado, T., Torre, A. S.-D. L., Bernal‐Chico, A., Matute, C., Mato, S., Guzmán, M., Galve‐Roperh, I., & Palazuelos, J. (2020) · Glia · doi:10.1002/glia.23911 · Cited by 35
Bolino, A. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01083-w · Cited by 33
Myelin Pathology Beyond White Matter in Tuberous Sclerosis Complex (TSC) Cortical Tubers
Mühlebner, A., van Scheppingen, J., de Neef, A., Bongaarts, A., Zimmer, T. S., Mills, J. D., Jansen, F. E., Spliet, W. G. M., Kršek, P., Zámečnı́k, J., et al. (2020) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlaa090 · Cited by 33
Yazdani, A., Howidi, B., Shi, M. Z., Tugarinov, N., Khoja, Z., & Wintermark, P. (2021) · Scientific Reports · doi:10.1038/s41598-021-01097-6 · Cited by 32
Hou, J., Bi, H., Ye, Z., Huang, W., Zou, G., Zou, X., Shi, Y. S., Shen, Y., Ma, Q., Kirchhoff, F., et al. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.2455-19.2021 · Cited by 29
Ornelas, I. M., Khandker, L., Wahl, S., Hashimoto, H., Macklin, W. B., & Wood, T. L. (2020) · Glia · doi:10.1002/glia.23776 · Cited by 29
The HERC proteins and the nervous system
Pérez-Villegas, E. M., Ruiz, R., Bachiller, S., Ventura, F., Armengol, J. A., & Rosa, J. L. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.11.017 · Cited by 32
Rab35-regulated lipid turnover by myotubularins represses mTORC1 activity and controls myelin growth
Sawade, L., Grandi, F., Mignanelli, M., Patiño‐López, G., Klinkert, K., Vives, F. L., Guardo, R. D., Échard, A., Bolino, A., & Haucke, V. (2020) · Nature Communications · doi:10.1038/s41467-020-16696-6 · Cited by 28
de la Monte, S. M. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230555 · Cited by 28
Myelin Defects in Niemann–Pick Type C Disease: Mechanisms and Possible Therapeutic Perspectives
Bernardo, A., Nuccio, C. D., Visentin, S., Martire, A., Minghetti, L., Popoli, P., & Ferrante, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168858 · Cited by 27
A Glance at the Molecules That Regulate Oligodendrocyte Myelination
Wang, S., Wang, Y., & Zou, S. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb44050149 · Cited by 24
Guerrero‐Valero, M., Grandi, F., Cipriani, S., Alberizzi, V., Guardo, R. D., Chicanne, G., Sawade, L., Bianchi, F., Carro, U. D., de Curtis, I., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2009469118 · Cited by 26
R-Ras GTPases Signaling Role in Myelin Neurodegenerative Diseases
Alcover‐Sanchez, B., Garcia‐Martin, G., Wandosell, F. G., & Cubelos, B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165911 · Cited by 24
Schwann cell energy to die for
Trimarco, A., & Taveggia, C. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-00707-2 · Cited by 25
Zheng, M., Liu, Z., Mana, L., Qin, G., Huang, S., Gong, Z., Tian, M., He, Y., & Wang, P. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114264 · Cited by 25
Pathways Involved in Remyelination after Cerebral Ischemia
Garcia‐Martin, G., Alcover‐Sanchez, B., Wandosell, F. G., & Cubelos, B. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210610093658 · Cited by 27
The TOR Pathway at the Neuromuscular Junction: More Than a Metabolic Player?
Castets, P., Ham, D. J., & Rüegg, M. A. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00162 · Cited by 29
Leitner, D., Kanshin, E., Askenazi, M., Siu, Y., Friedman, D. J., Devore, S., Jones, D. R., Ueberheide, B. M., Wısnıewskı, T., & Devinsky, O. (2022) · PLoS ONE · doi:10.1371/journal.pone.0268597 · Cited by 23
Machado, J., Silveira, W. A., Gonçalves, D. A. P., Schavinski, A. Z., Khan, M. M., Zanon, N. M., Díaz, M. B., Rudolf, R., Kettelhut, Í. D. C., & Navegantes, L. C. C. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.06.024 · Cited by 28
Maiuolo, J., Gliozzi, M., Musolino, V., Carresi, C., Nucera, S., Scicchitano, M., Scarano, F., Bosco, F., Oppedisano, F., Macrì, R., et al. (2020) · Biomedicines · doi:10.3390/biomedicines8120553 · Cited by 21
González‐Fernández, E., Jeong, H., Fukaya, M., Kim, H., Khawaja, R. R., Srivastava, I. N., Waisman, A., Son, Y., & Kang, S. H. (2018) · eLife · doi:10.7554/elife.32021 · Cited by 22
Thomas, L., & Pasquini, L. A. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1089-6 · Cited by 22
Ratti, S., Rusciano, I., Mongiorgi, S., Obeng, E. O., Cappellini, A., Teti, G., Falconi, M., Talozzi, L., Capellari, S., Bartoletti‐Stella, A., et al. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03661-1 · Cited by 25
Rivera, A. D., Pieropan, F., Williams, G. H., Calzolari, F., Butt, A. M., & Azim, K. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112436 · Cited by 22
The role of TSC1 and TSC2 proteins in neuronal axons
Karalis, V., Wood, D., Teaney, N. A., & Sahin, M. (2024) · Molecular Psychiatry · doi:10.1038/s41380-023-02402-7 · Cited by 21
Wang, H., Liu, M., Zou, G., Wang, L., Duan, W., He, X., Ji, M., Zou, X., Hu, Y., Yang, J., et al. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105212 · Cited by 21
Spatial omics reveals molecular changes in focal cortical dysplasia type II
Vermeulen, I., Rodriguez-Alvarez, N., François, L., Viot, D., Poosti, F., Aronica, E., Dedeurwaerdere, S., Barton, P., Cillero‐Pastor, B., & Heeren, R. M. A. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106491 · Cited by 20
Thomas, L., & Pasquini, L. A. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01787-3 · Cited by 18
Shi, Q., Saifetiarova, J., Taylor, A. M., & Bhat, M. A. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00201 · Cited by 19
Inamura, N., Kito, M., Go, S., Kishi, S., Hosokawa, M., Asai, K., Takakura, N., Takebayashi, H., Matsuda, J., & Enokido, Y. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.08.023 · Cited by 19
Saitoh, Y., Kamijo, A., Yamauchi, J., Sakamoto, T., & Terada, N. (2018) · Histochemistry and Cell Biology · doi:10.1007/s00418-018-1745-y · Cited by 19
mTOR pathway – a potential therapeutic target in stroke
Melanis, K., Stefanou, M., Themistoklis, K. M., & Papasilekas, T. (2023) · Therapeutic Advances in Neurological Disorders · doi:10.1177/17562864231187770 · Cited by 20
SGK1 drives hippocampal demyelination and diabetes-associated cognitive dysfunction in mice
Jiang, Z., Liu, B., Lu, T., Liu, X., Lv, R., Yuan, K., Zhu, M., Wang, X., Li, S., Xu, S., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56854-2 · Cited by 19
Jearjaroen, P., Thangwong, P., Tocharus, C., Chaichompoo, W., Suksamrarn, A., & Tocharus, J. (2023) · Inflammopharmacology · doi:10.1007/s10787-023-01406-7 · Cited by 18
Djuanda, D., He, B., Liu, X., Xu, S., Zhang, Y., Xu, Y., & Zhu, Z. (2021) · Journal of Molecular Neuroscience · doi:10.1007/s12031-020-01768-5 · Cited by 17
Sex-specific role of the optic gland in octopus maya: A transcriptomic analysis
Ventura-López, C., López-Galindo, L. L., Rosas, C., Sánchez‐Castrejón, E., Galindo-Torres, P., Pascual, C., Rodríguez‐Fuentes, G., Juárez, O. E., & Galindo‐Sánchez, C. E. (2022) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2022.114000 · Cited by 15
Molecular Pathogenic Mechanisms of Hypomyelinating Leukodystrophies (HLDs)
Torii, T., & Yamauchi, J. (2023) · Neurology International · doi:10.3390/neurolint15030072 · Cited by 16
D’Amore, A., Sundberg, M., Lin, R., Lubbers, E., Winden, K. D., Yu, L., Gawlińska, K., Gawliński, D., Lopez, S. G., Choe, Y., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-02916-2 · Cited by 15
Manipulating oligodendrocyte intrinsic regeneration mechanism to promote remyelination
Binamé, F., Pham-Van, L. D., & Bagnard, D. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03852-4 · Cited by 16
The molecular genetics of PI3K/PTEN/AKT/mTOR pathway in the malformations of cortical development
Ma, Q., Chen, G., Li, Y., Guo, Z., & Zhang, X. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.04.041 · Cited by 18
Nishino, S., Fujiki, Y., Sato, T., Kato, Y., Shirai, R., Oizumi, H., Yamamoto, M., Ohbuchi, K., Miyamoto, Y., Mizoguchi, K., et al. (2022) · Neurology International · doi:10.3390/neurolint14020039 · Cited by 14
Imbalance of NRG1-ERBB2/3 signalling underlies altered myelination in Charcot–Marie–Tooth disease 4H
El-Bazzal, L., Ghata, A. S., Estève, C., Gadacha, J., Quintana, P., Castro, C., Roëckel, N., Lembo, F., Lenfant, N., Mégarbané, A., et al. (2022) · Brain · doi:10.1093/brain/awac402 · Cited by 16
Zhang, T., Alonzo, I. G., Stubben, C., Geng, Y., Herdman, C., Chandler, N., Doane, K. P., Pluimer, B. R., Trauger, S. A., & Peterson, R. T. (2023) · Disease Models & Mechanisms · doi:10.1242/dmm.049995 · Cited by 14
Zhang, S.-J., Li, X.-X., Yu, Y., Chiu, A. P., Lo, L. H., To, J. C., Rowlands, D. K., & Keng, V. W. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.05.014 · Cited by 13
Shi, X.-Y., He, Y., Ge, M.-Y., Liu, P., Zheng, P., & Li, Z. (2025) · Acta Pharmacologica Sinica · doi:10.1038/s41401-025-01492-z · Cited by 13
The neuroinflammatory triumvirate: NF-κB, NLRP3, and mTOR in spinal cord injury
Darabniya, A. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01952-2 · Cited by 13
Sato, T., Shirai, R., Isogai, M., Yamamoto, M., Miyamoto, Y., & Yamauchi, J. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.07.092 · Cited by 13
Głowacka, A., Ji, B., Szczepankiewicz, A. A., Skup, M., & Gajewska‐Woźniak, O. (2022) · Biomedicines · doi:10.3390/biomedicines10112851 · Cited by 13
Garcia, P. A., Sánchez-Rueda, A., Velasco-Avilés, S., Tamayo-Caro, M., Ferrer-Pinós, A., Huarte-Sebastian, C., Álvarez, V., Riobello, C., Jiménez-Vega, S., Buendía, I., et al. (2024) · Science Advances · doi:10.1126/sciadv.adm7600 · Cited by 12
A RhoA-mediated biomechanical response in Schwann cells modulates peripheral nerve myelination
Seixas, A. I., Morais, M. R. G., Brakebusch, C., & Relvas, J. B. (2023) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2023.102481 · Cited by 12
Botticelli, E., Intriago, M. S. S., Piovesana, R., & Tata, A. M. (2022) · Life · doi:10.3390/life12020211 · Cited by 11
The Effects of Insulin on Immortalized Rat Schwann Cells, IFRS1
Saiki, T., Nakamura, N., Miyabe, M., Ito, M., Minato, T., Sango, K., Matsubara, T., & Naruse, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115505 · Cited by 11
Zhang, J., Li, W., Qi, Y., Liu, L., Hou, S., & Ju, J. (2023) · Neuroscience · doi:10.1016/j.neuroscience.2023.10.025 · Cited by 10
Targeting PI3K/Akt/mTOR signaling in rodent models of PMP22 gene-dosage diseases
Krauter, D., Stausberg, D., Hartmann, T. J., Volkmann, S., Kungl, T., Rasche, D. A., Saher, G., Fledrich, R., Stassart, R. M., Nave, K., et al. (2024) · EMBO Molecular Medicine · doi:10.1038/s44321-023-00019-5 · Cited by 11
Alcover‐Sanchez, B., Garcia‐Martin, G., Escudero‐Ramirez, J., González-Riaño, C., Lorenzo, P., Giménez-Cassina, A., Formentini, L., de la Villa, P., Pereira, M. P., Wandosell, F. G., et al. (2020) · Glia · doi:10.1002/glia.23917 · Cited by 10
de Abreu, M. S., Demin, K. A., Kotova, M. M., Mirzaei, F., Shariff, S., Kantawala, B., Zakharchenko, K. V., Kolesnikova, T. O., Dilbaryan, K., Grigoryan, A., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021530 · Cited by 10
Jiang, M.-Q., Rao, R., Wang, J.-C., Wang, J.-J., Xu, L.-L., Wu, L.-M., Chan, J. R., Wang, H.-M., & Lu, Q. R. (2018) · Glia · doi:10.1002/glia.23449 · Cited by 10
Sun, Y., Zhang, W., Men, L., Wu, J., Yao, L., Huang, X. X., Wu, Y., Zhang, C., Chen, Y., Carling, D., et al. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01386-8 · Cited by 12
Metadata
- Authors
- Figlia, G., Gerber, D., & Suter, U.
- Affiliations
- ETH Zurich (CH)
- Corresponding author
- Suter, Ueli
- Venue
- Glia
- Publisher
- Wiley
- Published
- 2017-12-06
- Volume
- 66
- Issue
- 4
- Pages
- 693-707
- ISSN
- 0894-1491 (ISSN-L)
- 1098-1136
- PMC
- PMC5836902
- OpenAlex
- W2772611711
- Cited by
- 165
- References
- 155
- Citations by year
- 2026: 14 · 2025: 19 · 2024: 15 · 2023: 23 · 2022: 18 · 2021: 21 · 2020: 26 · 2019: 15 · 2018: 13
- FWCI
- 2.23
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Glia (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Repository for Publications and Research Data (ETH Zurich) (submittedVersion, cc-by)
- ETH Zürich Research Collection (cc-by)
- Funders
- Swiss National Science Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Topics
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Keywords
- myelination, mTORC1, myelinating cells, glial metabolism, cellular metabolism, central nervous system myelination, peripheral nervous system myelination, PI3K/Akt signaling, MEK/ERK signaling, AMPK signaling
- MeSH terms
- Animals, Humans, Myelin Sheath, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review